COMMUNIQUÉS West-GlobeNewswire

CEO Ronan O’Caoimh Increases Shareholding in Trinity Biotech
29/11/2018
DUBLIN, Ireland, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), today announced that Ronan O’Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of [...]
Abeona Therapeutics to Host R&D Day on December 6, 2018
29/11/2018
NEW YORK and CLEVELAND, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
OraSure Technologies to Ring NASDAQ Stock Market Opening Bell in Honor of World AIDS Day
29/11/2018
OraSure Working to End AIDS on a Global Scale BETHLEHEM, Pa., Nov. 29, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, [...]
Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway
29/11/2018
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Clinical Genomics partners with the Colorectal Cancer Alliance in the Life After Cancer Mission
29/11/2018
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced its partnership with the Colorectal Cancer [...]
VistaGen Therapeutics Receives Hong Kong Patent for Methods of Production for AV-101
29/11/2018
New Hong Kong patent complements counterpart patents previously issued in China, Europe and the U.S. SOUTH SAN FRANCISCO, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage [...]
Todos Medical to Present Scientific Abstract at the Upcoming San Antonio Breast Cancer Symposium (SABCS)
29/11/2018
REHOVOT, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer, announced [...]
Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders
29/11/2018
Twelve-month data from the SUI feasibility study to be presented ENGLEWOOD, Colo., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, [...]
Spring Bank Announces Additional Pre-Clinical Data on Its Second-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
29/11/2018
HOPKINTON, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Mesa Labs Acquires Leading Continuous Monitoring Hardware Business
29/11/2018
Lakewood, Colorado, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced the acquisition of substantially all of the assets (other than current [...]
Maverick Technology Solutions’ ROSINBOMB™ Brand Featured in Marijuana Retail Report (MRR’s) Fall/Winter Tech Special Report
29/11/2018
RENO, Nev., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions’ highly acclaimed, ROSINBOMB™ line of extraction presses and technology is featured in MRR’s Fall/Winter Tech Special Report . MRR is a leading [...]
Zogenix to Host Investor Update Lunch on FINTEPLA® at the American Epilepsy Society 2018 Annual Meeting
29/11/2018
EMERYVILLE, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare diseases, today announced that it will host an Investor Update [...]
The Joint Corp. to Participate in the 7th Annual ROTH Deer Valley Corporate Access Event
29/11/2018
SCOTTSDALE, Ariz., Nov. 29, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to attend the 7 th Annual [...]
Poseida Therapeutics to Provide Update on Phase 1 Study of P-BCMA-101 at the 2018 American Society of Hematology Annual Meeting
29/11/2018
SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company focused on leveraging proprietary next-generation, non-viral gene engineering technologies to create [...]
Nevakar Completes $30 Million Financing to Advance Pipeline Products
29/11/2018
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today that it has [...]
PotNetwork Holdings, Inc.’s Diamond CBD Launches Program To Sell Its Products in Shopping Malls Across America on Black Friday at Broward Mall in South Florida
29/11/2018
New Program Focusing on Educating Consumers on the Benefits of Diamond CBD to Build Brand Preference FORT LAUDERDALE, Fla., Nov. 29, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holdings, Inc. (OTC Pink: POTN ) announced today [...]
AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia
29/11/2018
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals, Inc. ( [...]
Daré Bioscience, Inc. Announces Initiation of Content Validity Study for Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
29/11/2018
Sildenafil Cream, 3.6% has the Potential to Receive the First FDA Approval for Female Sexual Arousal Disorder SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc . (NASDAQ: DARE), a leader in clinical- [...]
InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)
29/11/2018
TEL AVIV, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery [...]

Pages